Cash & equivalents decreased 34.7%
Cash & equivalents changed -34.7% from the comparable as-filed period.
$4.9B→$3.2B2 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -34.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.